CoSara Diagnostics Private Limited receives permission from CDSCO to manufacture COVID-19 test with two target genes

CoSara Diagnostics Private Limited, a Joint Venture of a subsidiary of Ambalal Sarabhai Enterprises Limited and Co-Diagnostics, Inc, Salt Lake City, Utah, USA recently got permission to manufacture COVID-19 test with two target genes (RdRP & E) from CDSCO.

Like one gene test, this test is also highly specific and sensitive with fast and accurate diagnosis of COVID-19 infection with precise accuracy.

This is one more step towards commitment of providing diagnostic kits helpful in early diagnosis, evaluation and management of treatment.

Shares of AMBALAL SARABHAI ENTERPRISES LTD. was last trading in BSE at Rs.20.2 as compared to the previous close of Rs. 19.25. The total number of shares traded during the day was 55624 in over 173 trades.

The stock hit an intraday high of Rs. 20.2 and intraday low of 19.4. The net turnover during the day was Rs. 1108368.

Source : Equity Bulls

Keywords